Mr. John Connaghan:

There is no clinical lead after the resignation of the last clinical lead. We need a clinical lead to be able to close out the process. The Deputy asked what is the preference and I can answer from my perspective as director general. No matter what is the service, I have always had the preference to attempt to do as much insourcing as possible. However, that needs to measured in terms of resilience of the supply chain, value for money, quality etc. There are some caveats.